Study of a Reduced-toxicity Myeloablative Conditioning Regimen Using Fludarabine and Full Doses of Intravenous Busulfan in Pediatric Patients Not Eligible for Standard Myeloablative Conditioning Regimens (FB4-PEDIA)
This study is currently recruiting participants.
Verified March 2012 by Nantes University Hospital
Study NCT01572181
Information provided by Nantes University Hospital
First Received on February 21, 2012.
Last Updated on November 2, 2012
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
